Unlike more genetically heterogeneous cancers, PDAC is invariably initiated by an activating mutation in the proto-oncogene KRAS. However, KRAS-mutant epithelia can remain phenotypically normal and depend on inflammatory stimuli (pancreatitis) to transform into pre-neoplastic and neoplastic lesions (20–22). The gene discussed is KRAS; the disease is cancer.